Skip to main content

Table 5 Summary of adverse events during post-op

From: Impact of intra-operative cell salvage on blood coagulation in high-bleeding-risk patients undergoing cardiac surgery with cardiopulmonary bypass: a prospective randomized and controlled trial

Variable

Group CS (n = 53)

Group C (n = 50)

P value

Excessive bleeding

17 (32.08)

8 (16.00)

0.038

Resternotomy

3 (5.66)

2 (4.00)

1.000

Cardiovascular failure

6 (11.32)

7 (14.00)

0.682

Severe arrhythmias requiring treatment

4 (7.55)

3 (6.00)

1.000

Myocardial infarction

1 (1.89)

4 (8.00)

0.196

Infection

7 (13.21)

6 (12.00)

0.948

 Wound

3 (5.66)

2 (4.00)

1.000

 Others

4 (7.55)

4 (8.00)

1.000

Renal failure

5 (9.43)

4 (8.00)

1.000

Respiratory failure

3 (5.66)

2 (4.00)

1.000

Epileptic syndrome

1 (1.89)

1 (2.00)

1.000

Cognitive decline

0 (0.00)

3 (6.00)

0.111

Death

0 (0.00)

0 (0.00)

 
  1. Data are presented as number (percentage)